Ilable proof examined effectiveness of this multi-gene pharmacogenomic intervention over the short term (84 weeks57,58,61,62,64,65;
Ilable proof examined effectiveness of this multi-gene pharmacogenomic intervention over the short term (84 weeks57,58,61,62,64,65; see clinical assessment); no effectiveness Carbonic Anhydrase Inhibitor drug information on long-term outcomes which include…